EdmondJosephFitzgibbonMD
Ophthalmology • Bethesda, MDNeuro-Ophthalmology
Neuro-ophthalmology National Eye Institute, NIH Bethesda MD
Dr. Fitzgibbon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Rockville Pike
Rm 2A50
Bethesda, MD 20892Phone+1 301-496-7144Fax+1 301-402-0511
Summary
- Dr. Edmond Fitzgibbon is an ophthalmologist based in Bethesda, MD, specializing in neuro-ophthalmology. He completed an internship in internal medicine and residency in ophthalmology, with experience in general/comprehensive ophthalmology and neuro-ophthalmology. Dr. Fitzgibbon has contributed to research, having published several articles in noteworthy journals such as the Journal of Vision, NEJM, and JAMA. He has been involved in clinical trials focusing on neuro-degenerative diseases. Dr. Fitzgibbon served on the board of the North American Neuro-Ophthalmology Society and was President from 2016 to 2018. He is a Fellow of the American Academy of Ophthalmology.
Education & Training
Cleveland Clinic FoundationResidency, Ophthalmology, 1979 - 1984
Albany Medical CenterInternship, Internal Medicine, 1978 - 1979
Albany Medical CollegeClass of 1978
Certifications & Licensure
MD State Medical License 1990 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- President North American Neuro-Ophthalmology Society, 2016-2018
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Visual Motor Coordination Start of enrollment: 2007 Dec 04
- Screening for Research Participants Start of enrollment: 2008 Aug 20
- Evaluation and Treatment of People With Eye Diseases Start of enrollment: 2008 Jun 25
- Join now to see all
Publications & Presentations
PubMed
- Ocular-following responses to broadband visual stimuli of varying motion coherence.Boris M Sheliga, Edmond J FitzGibbon, Christian Quaia, Richard J Krauzlis
Journal of Vision. 2024-12-02 - Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease.Taylor McManus, Noa G Holtzman, Aaron Zhao, Chantal Cousineau-Krieger, Susan Vitale
Ophthalmology Science. 2024-09-30 - Weighted power summation and contrast normalization mechanisms account for short-latency eye movements to motion and disparity of sine-wave gratings and broadband visu...Boris M Sheliga, Edmond J FitzGibbon
Journal of Vision. 2024-08-01
Press Mentions
- Ocular Adverse Effects of Infigratinib, a New FGFR Tyrosine Kinase InhibitorSeptember 1st, 2020
Grant Support
- Neuro-Ophthalmic Mechanisms Of DiseaseNational Eye Institute2002–2008
- Neuro-ophthalmic Mechanisms Of DiseaseNATIONAL EYE INSTITUTEPresent
Professional Memberships
- Fellow
- North American Neuro-ophthalmology SocietyMember
- Society for NeuroscienceMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
